Arix Bioscience Aktie
WKN DE: A2DL9L / ISIN: GB00BD045071
Nachrichten zu Arix Bioscience PLC Registered Shs
12.02.24
|
Scheme Effective (EQS Group)
|
|
12.02.24
|
Suspension of Trading in Shares (EQS Group)
|
|
07.02.24
|
Transaction Update (EQS Group)
|
|
29.01.24
|
Results of First General Meeting (EQS Group)
|
|
24.01.24
|
Holding(s) in Company (EQS Group)
|
|
24.01.24
|
Holding(s) in Company (EQS Group)
|
|
23.01.24
|
||
22.01.24
|
||
19.01.24
|
||
19.01.24
|
Unaudited NAV for December 2023 (EQS Group)
|
|
08.01.24
|
||
05.01.24
|
Publication of Circular and RTW Bio Prospectus (EQS Group)
|
|
04.01.24
|
Holding(s) in Company (EQS Group)
|
|
22.12.23
|
||
13.12.23
|
Unaudited NAV for November 2023 (EQS Group)
|
|
08.12.23
|
||
13.11.23
|
||
10.11.23
|
||
10.11.23
|
PDMR Notification & Director Shareholding (EQS Group)
|
|
08.11.23
|
Unaudited NAV for October 2023 (EQS Group)
|
|
03.11.23
|
PDMR Notification & Director Shareholding (EQS Group)
|
|
02.11.23
|
PDMR Notification & Director Shareholding (EQS Group)
|
|
01.11.23
|
||
24.10.23
|
||
06.10.23
|
Unaudited NAV for September 2023 (EQS Group)
|
|
27.09.23
|
Board Change (EQS Group)
|